Paul Klenerman

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

Cheryl L. Day, Daniel E. Kaufmann, Photini Kiepiela et al. · Nature · 2006 · 2.6K citations

Life Sciences, Immunology, Infectious Diseases +17

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

Victor Appay, P. Rod Dunbar, Margaret Callan et al. · Nature Medicine · 2002 · 1.6K citations

Life Sciences, Immunology, Microbiology +16

Genetic mechanisms of critical illness in COVID-19

Erola Pairo‐Castineira, Sara Clohisey, Lucija Klarić et al. · Nature · 2020 · 1.5K citations · Full text

Life Sciences, Genetics, Infectious Diseases +11